Keyphrases
Adverse Effects
20%
American College of Rheumatology Criteria
20%
Autologous Mesenchymal Stem Cells
100%
Bone Marrow Mononuclear Cells
20%
CD4+CD25+Foxp3+
40%
Cell Count
20%
Cell Infusion
20%
Disease Activity
100%
Disease Activity Score
40%
Disease Model
20%
Flow Cytometry
20%
Human Mesenchymal Stem Cells (hMSCs)
40%
Immunological Parameters
20%
In Vitro Suppression
20%
Index Parameters
20%
Inflammatory Milieu
20%
Lupus
20%
Lupus-prone Mice
20%
Lymphocyte Function
20%
Lymphocytes T
20%
Mesenchymal Stem Cell Therapy
100%
Mesenchymal Stem Cells
100%
No Adverse Effect
20%
Peripheral Blood Lymphocyte Subsets
20%
Peripheral Blood Lymphocytes
20%
Regulatory T (Treg) Cells
100%
Renal Disease
20%
Renal Flare
20%
Response to Treatment
20%
Suppression Effect
60%
Systemic Lupus Erythematosus
40%
Systemic Lupus Erythematosus Patient
100%
Medicine and Dentistry
Adverse Event
33%
Bone Marrow Derived Mesenchymal Stem Cell
33%
Cell Count
16%
Disease Activity
100%
Disease Model
16%
Flow Cytometry
16%
In Vitro
50%
Infusion
33%
Lupus Erythematosus
33%
Lymphocyte Function
16%
Lymphocyte Subpopulation
16%
Mesenchymal Stem Cell
100%
Mesenchymal Stem Cell Transplantation
16%
Nephropathy
16%
Regulatory T Cell
100%
Rheumatology
16%
Systemic Lupus Erythematosus
100%
Immunology and Microbiology
Bone Marrow Derived Mesenchymal Stem Cell
33%
CD25
33%
CD4
33%
Cell Count
16%
Lupus Erythematosus
33%
Lymphocyte Function
16%
Lymphocyte Subpopulation
16%
Mesenchymal Stem Cell
100%
Mesenchymal Stem Cell Transplantation
16%
Peripheral Blood Lymphocyte
50%
Regulatory T Cell
100%
Systemic Lupus Erythematosus
100%
Biochemistry, Genetics and Molecular Biology
Bone Marrow-Derived Mesenchymal Stem Cells
40%
CD25
40%
CD4
40%
Cell Count
20%
Flow Cytometry
20%
Induced Stem Cells
20%
Lymphocyte Function
20%
Lymphocyte Subpopulation
20%
Mesenchymal Stem Cell Transplantation
20%
Peripheral Blood Lymphocyte
60%
Regulatory T Cell
100%
Stem Cell
100%
Neuroscience
Adverse Effect
22%
CD4
22%
Cell Therapy
11%
Flow Cytometry
11%
In Vitro
33%
Lupus Erythematosus
22%
Lymphocyte
11%
Lymphocyte Subpopulation
11%
Mesenchymal Stem Cell
100%
Rheumatology
11%
Systemic Lupus Erythematosus
100%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
40%
Disease Activity
100%
Disease Model
20%
Flow Cytometry
20%
Kidney Disease
20%
Systemic Lupus Erythematosus
100%